Literature DB >> 2124956

Tumour necrosis factor production in fulminant hepatic failure: relation to aetiology and superimposed microbial infection.

M de la Mata1, A Meager, N Rolando, H M Daniels, K T Nouri-Aria, A K Goka, A L Eddleston, G J Alexander, R Williams.   

Abstract

Tumour necrosis factor-alpha (TNF-alpha), a cytokine derived from macrophages, is considered to be an important endogenous mediator of endotoxic shock. Patients with fulminant hepatic failure are particularly susceptible to infection and the development of multi-organ failure and similarities to endotoxic shock suggest a possible pathogenetic role for TNF in fulminant hepatic failure. In vitro TNF production was therefore investigated serially in 21 consecutive patients with fulminant hepatic failure and in 21 healthy controls. Spontaneous and lipopolysaccharide-stimulated TNF production were elevated in viral-induced fulminant hepatic failure, compared with healthy controls (P less than 0.05 and P less than 0.01, respectively). By contrast, patients with paracetamol-induced fulminant hepatic failure had normal spontaneous and lipopolysaccharide-stimulated TNF production, while those who died had significantly reduced spontaneous TNF production compared with survivors (P less than 0.02); this difference was present throughout admission. In this group elevations in TNF production above baseline were associated with Gram-positive bacterial or fungal infection but not Gram-negative bacterial infection. There was no correlation between any of the clinical complications of fulminant microbial stimuli in fulminant hepatic failure, but do not support a direct role for TNF in the evolution of the clinical complications of fulminant hepatic failure.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2124956      PMCID: PMC1535494          DOI: 10.1111/j.1365-2249.1990.tb05475.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

Review 1.  Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities.

Authors:  J Le; J Vilcek
Journal:  Lab Invest       Date:  1987-03       Impact factor: 5.662

Review 2.  Cachectin: more than a tumor necrosis factor.

Authors:  B Beutler; A Cerami
Journal:  N Engl J Med       Date:  1987-02-12       Impact factor: 91.245

3.  Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia.

Authors:  K J Tracey; Y Fong; D G Hesse; K R Manogue; A T Lee; G C Kuo; S F Lowry; A Cerami
Journal:  Nature       Date:  1987 Dec 17-23       Impact factor: 49.962

4.  Antiviral effects of recombinant tumour necrosis factor in vitro.

Authors:  J Mestan; W Digel; S Mittnacht; H Hillen; D Blohm; A Möller; H Jacobsen; H Kirchner
Journal:  Nature       Date:  1986 Oct 30-Nov 5       Impact factor: 49.962

5.  Tumor necrosis factor mediates endotoxic effects in mice.

Authors:  F Bauss; W Dröge; D N Männel
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

Review 6.  Natural production and release of tumour necrosis factor.

Authors:  G E Gifford; D A Flick
Journal:  Ciba Found Symp       Date:  1987

7.  Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease.

Authors:  A Waage; A Halstensen; T Espevik
Journal:  Lancet       Date:  1987-02-14       Impact factor: 79.321

8.  Detection of circulating tumor necrosis factor after endotoxin administration.

Authors:  H R Michie; K R Manogue; D R Spriggs; A Revhaug; S O'Dwyer; C A Dinarello; A Cerami; S M Wolff; D W Wilmore
Journal:  N Engl J Med       Date:  1988-06-09       Impact factor: 91.245

9.  Preparation and characterization of monoclonal antibodies directed against antigenic determinants of recombinant human tumour necrosis factor (rTNF).

Authors:  A Meager; S Parti; H Leung; E Peil; B Mahon
Journal:  Hybridoma       Date:  1987-06

10.  Effect of gamma interferon on cachectin expression by mononuclear phagocytes. Reversal of the lpsd (endotoxin resistance) phenotype.

Authors:  B Beutler; V Tkacenko; I Milsark; N Krochin; A Cerami
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

View more
  12 in total

Review 1.  Infectious complications of liver disease.

Authors:  P D King
Journal:  J Gen Intern Med       Date:  1993-06       Impact factor: 5.128

2.  Stem cell factor restores hepatocyte proliferation in IL-6 knockout mice following 70% hepatectomy.

Authors:  Xiaodan Ren; Cory Hogaboam; Audra Carpenter; Lisa Colletti
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

3.  Prevention of endotoxin-induced acute lethality in Propionibacterium acnes-primed rabbits by an antibody to leukocyte integrin beta 2 with concomitant reduction of cytokine production.

Authors:  N Ikeda; N Mukaida; S Kaneko; N Fujioka; S Su; H Nariuchi; M Unoura; K Harada; Y Nakanuma; K Kobayashi
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

4.  Association of tumor necrosis factor-alpha gene promoter polymorphisms with acute viral hepatitis in the Indian population.

Authors:  Shashideep Singhal; Indu Kohaar; Mausumi Bharadwaj; Deepak K Shukla; Bhudev C Das; Premashis Kar
Journal:  Dig Dis Sci       Date:  2009-04-24       Impact factor: 3.199

5.  Selective suppression of NF-kBp65 in hepatitis virus-infected pregnant women manifesting severe liver damage and high mortality.

Authors:  Bhupesh K Prusty; Suresh Hedau; Ajay Singh; Premasis Kar; Bhudev C Das
Journal:  Mol Med       Date:  2007 Sep-Oct       Impact factor: 6.354

6.  Serum hyaluronate in patients with acute and fulminant hepatitis.

Authors:  K Suzuki; R Endo; Y Takikawa; I Nakadate; S Sato
Journal:  J Gastroenterol       Date:  1996-04       Impact factor: 7.527

7.  Prognostic significance of infections in critically ill adult patients with acute liver injury: a retrospective cohort study.

Authors:  Alexander D Zider; Radhika Zopey; Ronak Garg; Xiaoyan Wang; Tisha S Wang; Jane C Deng
Journal:  Liver Int       Date:  2016-04-04       Impact factor: 5.828

8.  Toll-like receptor-2 exacerbates murine acute viral hepatitis.

Authors:  Christian Bleau; Mélanie Burnette; Aveline Filliol; Claire Piquet-Pellorce; Michel Samson; Lucie Lamontagne
Journal:  Immunology       Date:  2016-08-10       Impact factor: 7.397

9.  Promoter methylation status and expression of PPAR-γ gene are associated with prognosis of acute-on-chronic hepatitis B liver failure.

Authors:  Ze-Hua Zhao; Yu-Chen Fan; Qi Zhao; Cheng-Yun Dou; Xiang-Fen Ji; Jing Zhao; Shuai Gao; Xin-You Li; Kai Wang
Journal:  Clin Epigenetics       Date:  2015-10-28       Impact factor: 6.551

10.  Functional role of monocytes and macrophages for the inflammatory response in acute liver injury.

Authors:  Henning W Zimmermann; Christian Trautwein; Frank Tacke
Journal:  Front Physiol       Date:  2012-10-19       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.